eptifibatide
As of June 2016, eptifibatide is a non-formulary medication. The formulary Glycoprotein 2b/3a Inhibitor agent of choice is tirofiban. Eptifibatide may be available for patients already started on medication outside of Legacy Health.
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
Cardiac/Telemetry Units: Guidelines for cardiac and vasoactive IV drugs: See Policy 900.5386
As of June 2016, eptifibatide is a non-formulary medication. The formulary Glycoprotein 2b/3a Inhibitor agent of choice is tirofiban. Eptifibatide may be available for patients already started on medication outside of Legacy Health.
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
Cardiac/Telemetry Units: Guidelines for cardiac and vasoactive IV drugs: See Policy 900.5386